Integra Lifesciences Holdings (IART) has a PEG ratio of 178.93, above the Healthcare sector average of 11.64.
Get informed when a big investor buys or sells
+ Follow178.93
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, IART shows a PEG ratio of 178.93. That is above the Healthcare sector average of 11.64. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 11.64. Integra Lifesciences Holdings is at 178.93, which is higher that average. That is roughly 1437.1% above the sector mean. Use the comparison chart on this page to see how IART stacks up against individual peers as well.
Investors watch IART's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Integra Lifesciences Holdings's latest reading is 178.93. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Integra Lifesciences Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 178.93) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 11.64, while IART is at 178.93. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.